Tandem Diabetes Care (TNDM) Convertible Debt (2020 - 2026)

Tandem Diabetes Care's Convertible Debt history runs 7 years deep, the most recent figure standing at $601.8 million for Q1 2026.

• Quarterly Convertible Debt rose 94.93% year-over-year to $601.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $601.8 million (up 94.93% YoY) and the FY2025 annual result came in at $310.0 million, up 0.57% from the prior year.
• Convertible Debt was $601.8 million for Q1 2026 at Tandem Diabetes Care, up from $310.0 million in the prior quarter.
• Across five years, Convertible Debt topped out at $601.8 million in Q1 2026 and bottomed at $281.9 million in Q1 2022.
• A 5-year average of $316.3 million and a median of $307.4 million in 2024 frame the typical range for Convertible Debt.
• Annual changes were most pronounced in 2025 — Convertible Debt dropped 11.16% — and 2026, when it surged 94.93%.
• Tandem Diabetes Care's Convertible Debt stood at $283.2 million in 2022, then gained by 0.64% to $285.0 million in 2023, then advanced by 8.15% to $308.3 million in 2024, then increased by 0.57% to $310.0 million in 2025, then surged by 94.1% to $601.8 million in 2026.
• Business Quant data shows TNDM's Convertible Debt at $601.8 million in Q1 2026, $310.0 million in Q4 2025, and $309.6 million in Q3 2025.